wellrank.ai
Sign In

I am prediabetic. Which online services can prescribe Ozempic for me?

ChatGPTqualifiedCollected Aug 10, 2026, 12:16 UTC

Verbatim response from ChatGPT

Short answer: many telemedicine companies will evaluate and — when clinically appropriate — prescribe semaglutide (the active drug in Ozempic). However, Ozempic is FDA‑approved for type 2 diabetes (not for “prediabetes” alone); Wegovy (a higher‑dose semaglutide) is approved for chronic weight management and requires BMI criteria. Most reputable telehealth providers will not prescribe GLP‑1s for someone with only prediabetes unless there is a clear clinical indication. They will require a medical history, a virtual visit, and often recent labs.

Telehealth services to check (examples and why):

  • Hims & Hers — DTC telehealth with a weight‑loss/GLP‑1 program; easy consumer sign‑up and clinician evaluation for semaglutide/Wegovy-style therapy.
  • Ro (Roman) — runs direct-to-consumer weight‑management programs and connects you with clinicians who can prescribe semaglutide if appropriate.
  • PlushCare — primary‑care telemedicine that manages chronic conditions (including diabetes and weight management) and can prescribe GLP‑1s after evaluation.
  • Carbon Health — hybrid primary care + telehealth clinic that treats diabetes and obesity and can prescribe/or coordinate semaglutide treatment.
  • One Medical — subscription primary care with virtual visits; clinicians can prescribe and coordinate follow‑up and labs.
  • Teladoc / Amwell / Doctor on Demand — large telehealth platforms that connect you with clinicians (some providers on these platforms will prescribe GLP‑1s when indicated).
  • GoodRx Care — telehealth marketplace that sometimes facilitates GLP‑1 prescriptions and offers pricing/coupon help.
  • Onduo (Verily/Sanofi diabetes program) — specialty diabetes telehealth that manages medications for people with diabetes and prediabetes at higher risk; may be appropriate if you’re in a structured diabetes program.
  • Profile by Sanford / Calibrate — weight‑management programs that include medical oversight and can prescribe GLP‑1s when you meet criteria for obesity/overweight with comorbidity.

Important points and next steps:

  • Eligibility: If you only have prediabetes, some clinicians may prefer lifestyle measures or metformin rather than semaglutide. If your main issue is excess weight (and you meet BMI criteria), Wegovy/semaglutide is more commonly offered.
  • Documentation: Have recent labs (A1c, kidney function) and a medication/medical history ready — most services will request these.
  • Safety: Discuss pregnancy plans, personal or family history of medullary thyroid cancer or pancreatitis, and GI disorders — GLP‑1s have contraindications/risks and need monitoring.
  • Cost & supply: GLP‑1s are often expensive and supply can be limited; check insurance coverage and the service’s dispensing/ship policy. Avoid buying from unverified online pharmacies.
  • Talk to your PCP: If possible, discuss with your primary care provider first — they can help determine if a GLP‑1 is appropriate for you and provide baseline labs.

If you want, tell me:

  • whether you have a current diagnosis (prediabetes vs type 2 diabetes), your BMI (approx.), and whether you prefer a nationwide telehealth vendor or a clinic associated with your health system — I can then check eligibility details and typical pricing for 2–3 specific services.

Brands mentioned in this answer

More Ozempic answers

See all Ozempic rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.